Versant Venture Capital VI, L.P. has filed 84 insider transactions across 6 companies since March 2024.
Most recent transaction: a sale of 123 shares of LENZ Therapeutics, Inc. ($LENZ) on September 30, 2025.
Activity breakdown: 0 open-market purchases and 52 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 123 | $47.01 | 2,656,888.0000 | 27,542,874 | 0.00% | 0.00% |
| Sept. 30, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 49701 | $45.35 | 2,740,131.0000 | 27,542,874 | 1.78% | 0.18% |
| Sept. 30, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 34405 | $45.35 | 2,714,513.0000 | 27,542,874 | 1.25% | 0.12% |
| Sept. 30, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 83066 | $46.41 | 2,657,065.0000 | 27,542,874 | 3.03% | 0.30% |
| Sept. 30, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 57502 | $46.41 | 2,657,011.0000 | 27,542,874 | 2.12% | 0.21% |
| Sept. 30, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 177 | $47.01 | 2,656,888.0000 | 27,542,874 | 0.01% | 0.00% |
| Sept. 19, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 532870 | $1.40 | 0.0000 | 26,899,122 | 100.00% | 1.98% |
| Sept. 19, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 2370533 | $1.40 | 0.0000 | 26,899,122 | 100.00% | 8.81% |
| Sept. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 24370 | $41.59 | 2,902,142.0000 | 27,542,874 | 0.83% | 0.09% |
| Sept. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 40907 | $43.00 | 2,882,130.0000 | 27,542,874 | 1.40% | 0.15% |
| Sept. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 20148 | $43.00 | 2,881,994.0000 | 27,542,874 | 0.69% | 0.07% |
| Sept. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 268 | $43.30 | 2,881,862.0000 | 27,542,874 | 0.01% | 0.00% |
| Sept. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 132 | $43.30 | 2,881,862.0000 | 27,542,874 | 0.00% | 0.00% |
| Sept. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 49479 | $41.59 | 2,923,037.0000 | 27,542,874 | 1.66% | 0.18% |
| Sept. 18, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 366111 | $1.44 | 2,903,403.0000 | 26,899,122 | 11.20% | 1.36% |
| Sept. 17, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 226726 | $1.49 | 3,132,194.0000 | 26,899,122 | 6.75% | 0.84% |
| Sept. 17, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 362806 | $1.49 | 3,269,514.0000 | 26,899,122 | 9.99% | 1.35% |
| Sept. 16, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 192293 | $1.53 | 3,358,920.0000 | 26,899,122 | 5.41% | 0.71% |
| Sept. 16, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 307707 | $1.53 | 3,632,320.0000 | 26,899,122 | 7.81% | 1.14% |
| Sept. 18, 2025 | LAVA Therapeutics NV | $LVTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 228791 | $1.44 | 2,903,403.0000 | 26,899,122 | 7.30% | 0.85% |
| Aug. 22, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 10076 | $40.03 | 3,069,161.0000 | 27,542,874 | 0.33% | 0.04% |
| Aug. 26, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 1707 | $39.50 | 3,017,166.0000 | 27,542,874 | 0.06% | 0.01% |
| Aug. 26, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 3465 | $39.50 | 3,017,166.0000 | 27,542,874 | 0.11% | 0.01% |
| Aug. 26, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 21661 | $38.97 | 3,018,873.0000 | 27,542,874 | 0.71% | 0.08% |
| Aug. 26, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 43978 | $38.97 | 3,020,631.0000 | 27,542,874 | 1.44% | 0.16% |
| Aug. 25, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 1058 | $39.92 | 3,040,534.0000 | 27,542,874 | 0.03% | 0.00% |
| Aug. 25, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 2149 | $39.92 | 3,064,609.0000 | 27,542,874 | 0.07% | 0.01% |
| Aug. 25, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 24760 | $39.53 | 3,041,592.0000 | 27,542,874 | 0.81% | 0.09% |
| Aug. 25, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 50270 | $39.53 | 3,066,758.0000 | 27,542,874 | 1.61% | 0.18% |
| Aug. 22, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 2809 | $40.59 | 3,066,352.0000 | 27,542,874 | 0.09% | 0.01% |
| Aug. 22, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 5668 | $40.59 | 3,117,028.0000 | 27,542,874 | 0.18% | 0.02% |
| Aug. 22, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 20493 | $40.03 | 3,122,696.0000 | 27,542,874 | 0.65% | 0.07% |
| Aug. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 30628 | $38.56 | 3,205,260.0000 | 27,542,874 | 0.95% | 0.11% |
| Aug. 15, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 145051 | $39.50 | 3,235,888.0000 | 27,542,874 | 4.29% | 0.53% |
| Aug. 15, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 69949 | $39.50 | 3,220,345.0000 | 27,542,874 | 2.13% | 0.25% |
| Aug. 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 15085 | $38.56 | 3,205,260.0000 | 27,542,874 | 0.47% | 0.05% |
| July 10, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 191376 | $34.00 | 3,465,973.0000 | 27,542,874 | 5.23% | 0.69% |
| June 27, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 200000 | $30.47 | 3,657,349.0000 | 27,542,874 | 5.18% | 0.73% |
| June 18, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 100000 | $29.95 | 3,958,226.0000 | 27,542,874 | 2.46% | 0.36% |
| June 20, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 100877 | $30.35 | 3,857,349.0000 | 27,542,874 | 2.55% | 0.37% |
| June 20, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 133924 | $30.25 | 3,857,349.0000 | 27,542,874 | 3.36% | 0.49% |
| June 10, 2025 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 350000 | $29.00 | 4,192,150.0000 | 27,542,874 | 7.71% | 1.27% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 20397 | $0.00 | 4,099,866.0000 | 82,011,670 | 0.50% | 0.02% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 20397 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.50% | 0.02% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 17595 | $0.00 | 4,097,064.0000 | 82,011,670 | 0.43% | 0.02% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 17595 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.43% | 0.02% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5454 | $0.00 | 4,084,923.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5499 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 366590 | $0.00 | 5,720,827.0000 | 82,011,670 | 6.02% | 0.45% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5499 | $0.00 | 4,084,968.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 29, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 15600 | $9.41 | 5,652,922.0000 | 82,011,670 | 0.28% | 0.02% |
| Oct. 29, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 52305 | $9.08 | 5,668,522.0000 | 82,011,670 | 0.91% | 0.06% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5454 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 89990 | $9.66 | 6,087,417.0000 | 82,011,670 | 1.46% | 0.11% |
| Oct. 28, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 1019867 | $0.00 | 5,652,922.0000 | 82,011,670 | 15.28% | 1.24% |
| Sept. 20, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 1132566 | $6.53 | 7,197,274.0000 | 51,396,961 | 13.60% | 2.20% |
| Sept. 13, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 9269 | $6.16 | 8,329,840.0000 | 51,396,961 | 0.11% | 0.02% |
| Sept. 11, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 541897 | $6.00 | 8,355,156.0000 | 51,396,961 | 6.09% | 1.05% |
| Sept. 12, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 16047 | $6.00 | 8,339,109.0000 | 51,396,961 | 0.19% | 0.03% |
| Aug. 28, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 221600 | $6.32 | 6,206,964.0000 | 43,954,649 | 3.45% | 0.50% |
| Aug. 8, 2024 | Tempest Therapeutics, Inc. | $TPST | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 400000 | $1.35 | 3,895,055.0000 | 0 | 9.31% | 0.00% |
| Aug. 12, 2024 | Tempest Therapeutics, Inc. | $TPST | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 387999 | $1.10 | 3,507,056.0000 | 0 | 9.96% | 0.00% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series C Preferred Stock | 275769 | $0.00 | 710,494.0000 | 2,308,972 | 63.44% | 11.94% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series C Preferred Stock | 689 | $0.00 | 12,123.0000 | 2,308,972 | 6.03% | 0.03% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series C Preferred Stock | 110187 | $0.00 | 1,934,776.0000 | 2,308,972 | 6.04% | 4.77% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series B Preferred Stock | 317988 | $0.00 | 2,175,832.0000 | 2,308,972 | 17.12% | 13.77% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series B Preferred Stock | 434725 | $0.00 | 2,175,832.0000 | 2,308,972 | 24.97% | 18.83% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series B Preferred Stock | 2182 | $0.00 | 1,752,541.0000 | 2,308,972 | 0.12% | 0.09% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series B Preferred Stock | 348143 | $0.00 | 3,565,696.0000 | 2,308,972 | 10.82% | 15.08% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series A-1 Preferred Stock | 1423119 | $0.00 | 1,423,119.0000 | 2,308,972 | 9999.99% | 61.63% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series A Preferred Stock | 9252 | $0.00 | 9,252.0000 | 2,308,972 | 9999.99% | 0.40% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series A Preferred Stock | 1476446 | $0.00 | 1,476,446.0000 | 2,308,972 | 9999.99% | 63.94% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series C Preferred Stock | 57565 | $0.00 | 0.0000 | 2,308,972 | 0.00% | 2.49% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series C Preferred Stock | 145 | $0.00 | 0.0000 | 2,308,972 | 0.00% | 0.01% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series C Preferred Stock | 22312 | $0.00 | 0.0000 | 2,308,972 | 0.00% | 0.97% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series B Preferred Stock | 90747 | $0.00 | 1,741,107.0000 | 2,308,972 | 5.50% | 3.93% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series B Preferred Stock | 455 | $0.00 | 1,741,107.0000 | 2,308,972 | 0.03% | 0.02% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series B Preferred Stock | 70498 | $0.00 | 1,741,107.0000 | 2,308,972 | 4.22% | 3.05% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series A Preferred Stock | 1931 | $0.00 | 0.0000 | 2,308,972 | 0.00% | 0.08% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Class A Common Stock | 391785 | $0.00 | 767,320.0000 | 2,308,972 | 104.33% | 16.97% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Class A Common Stock | 2531 | $0.00 | 378,066.0000 | 2,308,972 | 0.67% | 0.11% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Class A Common Stock | 148312 | $0.00 | 523,847.0000 | 2,308,972 | 39.49% | 6.42% |
| April 9, 2024 | Contineum Therapeutics, Inc. | $CTNM | Versant Venture Capital VI, L.P. | TenPercentOwner | C | Series A Preferred Stock | 298975 | $0.00 | 0.0000 | 2,308,972 | 0.00% | 12.95% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 598203 | $0.00 | 4,542,150.0000 | 0 | 15.17% | 0.00% |